Cart
sales@molnova.com
E,E-RAMB4
CAS No. 919091-61-5
E,E-RAMB4( —— )
Catalog No. M33081 CAS No. 919091-61-5
PTP1B-IN-8 is a potent and selective inhibitor of protein tyrosine phosphatase-1B (PTP1B).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 135 | Get Quote |
|
| 5MG | 187 | Get Quote |
|
| 10MG | 283 | Get Quote |
|
| 25MG | 438 | Get Quote |
|
| 50MG | 624 | Get Quote |
|
| 100MG | 821 | Get Quote |
|
| 200MG | 1071 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameE,E-RAMB4
-
NoteResearch use only, not for human use.
-
Brief DescriptionPTP1B-IN-8 is a potent and selective inhibitor of protein tyrosine phosphatase-1B (PTP1B).
-
Description(E,E)-RAMB4 is a potent and selective potent protein tyrosine phosphatase-1B (PTP1B) inhibitor extracted from patent CN103626692A, example 1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorPhosphatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number919091-61-5
-
Formula Weight413.12
-
Molecular FormulaC19H13Cl4NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClc1ccc(\C=C2/CNC\C(=C/c3ccc(Cl)c(Cl)c3)C2=O)cc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jin, Yongsheng, et al. 3,5-diaryl-ylidene piperidone derivatives and application thereof in preparing blood glucose-reducing and fat-reducing medicine. CN103626692A.
molnova catalog
related products
-
BPDA2
BPDA2 is a highly selective and competitive SHP2 inhibitor, exhibiting IC50 values of 92.0 nM for SHP2, and 33.39 μM and 40.71 μM for SHP1 and SHP1B, respectively.
-
LMPTP INHIBITOR 1 hy...
LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP) with an IC50 of 0.8 μM LMPTP-A.
-
JMS-053
JMS-053 is a potent and selective inhibitor of the phosphatase DUSP3, inhibits PTP4A3, PTP4A1, PTP4A2 and CDC25B, inhibits cancer cell migration and sphere growth, and avoids disruption of the microvascular endothelial barrier by vascular endothelial growth factor or lipopolysaccharide.
